Use of all cause mortality to quantify the consequences of covid-19 in Nembro, Lombardy: descriptive study
- PMID: 32409488
- PMCID: PMC7223479
- DOI: 10.1136/bmj.m1835
Use of all cause mortality to quantify the consequences of covid-19 in Nembro, Lombardy: descriptive study
Abstract
Objective: To quantify the impact of coronavirus disease 2019 (covid-19) on all cause mortality in Nembro, an Italian city severely affected by the covid-19 pandemic.
Design: Descriptive study.
Setting: Nembro, in the Bergamo province of Lombardy, northern Italy.
Population: Residents of Nembro.
Main outcome measures: Monthly all cause mortality between January 2012 and April 2020 (data to 11 April), number of confirmed deaths from covid-19 to 11 April 2020, and weekly absolute number of deaths between 1 January and 4 April across recent years by age group and sex.
Results: Nembro had 11 505 residents as of 1 January 2020. Monthly all cause mortality between January 2012 and February 2020 fluctuated around 10 per 1000 person years, with a maximum of 21.5 per 1000 person years. In March 2020, monthly all cause mortality reached a peak of 154.4 per 1000 person years. For the first 11 days in April, this rate decreased to 23.0 per 1000 person years. The observed increase in mortality was driven by the number of deaths among older people (≥65 years), especially men. From the outbreak onset until 11 April 2020, only 85 confirmed deaths from covid-19 in Nembro were recorded, corresponding to about half of the 166 deaths from all causes observed in that period.
Conclusions: The study findings show how covid-19 can have a considerable impact on the health of a small community. Furthermore, the results suggest that the full implications of the covid-19 pandemic can only be completely understood if, in addition to confirmed deaths related to covid-19, consideration is also given to all cause mortality in a given region and time frame.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare the following competing interests: no support from any organisation for the submitted work; JLR is funded by a grant from the Else-Kröner-Fresenius Foundation (www.ekfs.de, GSO/EKFS-17; TK was the grant recipient). She further reports receiving a research grant from the Soyka Award for Pain Research 2019 sponsored by the German Migraine and Headache Society (DMKG) and Novartis Pharma for work outside this project. LF and CL are employed by Centro Medico Santagostino, a polyclinic that offers private healthcare services in Lombardy. Centro Medico Santagostino is planning to conduct scientific research on the impact of serological testing on covid-19 detection in the coming months, independent of this project. TK reports outside the submitted work to have contributed to an advisory board of CoLucid and a research project funded by Amgen, for which the Charité - Universitätsmedizin Berlin received unrestricted compensation. He further reports having received honorariums from Lilly, Newsenselab, and Total for providing methodological advice, from Novartis and Daiichi Sankyo for providing a lecture on neuroepidemiology and research methods, and from The BMJ for editorial services.
Figures
Comment in
-
Covid-19: excess all cause mortality in domiciliary care.BMJ. 2020 Jul 13;370:m2751. doi: 10.1136/bmj.m2751. BMJ. 2020. PMID: 32660936 No abstract available.
References
-
- Callaway E. Time to use the p-word? Coronavirus enters dangerous new phase. Nature 2020; published online 25 February. - PubMed
-
- Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA 2020. - PubMed
-
- COVID-19 Map. Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html (accessed 2 May 2020).
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous